BERMOXEL

This brand name is authorized in Cyprus, Malta

Active ingredients

The drug BERMOXEL contains one active pharmaceutical ingredient (API):

1 Praziquantel UNII 6490C9U457 - PRAZIQUANTEL

Praziquantel induces a rapid contraction of schistosomes by a specific effect on the permeability of the cell membrane. The medicine further causes vacuolisation and disintegration of the schistosome tegument. Read about Praziquantel

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BERMOXEL Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P02BA01	Praziquantel	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02B Antitrematodals → P02BA Quinoline derivatives and related substances
Discover more medicines within P02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): AA565/45301